Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1616588

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1616588

LAMEA Biosimulation Market Size, Share & Trends Analysis Report By Product, By Pricing Model, By End Use, By Application, By Deployment Model (Cloud-based, On-premises, and Hybrid Model), By Therapeutic Area, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Biosimulation Market would witness market growth of 19.4% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Biosimulation Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $215.1 million by 2031. The Argentina market is showcasing a CAGR of 20.1% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 19.1% during (2024 - 2031).

For biosimilars, they ensures their equivalence to original biologics by simulating pharmacokinetic and pharmacodynamic (PK/PD) profiles. This reduces the need for extensive comparative trials, saving time and resources. For instance, this has been used to demonstrate the bioequivalence of insulin biosimilars, ensuring they perform identically to the original products.

While traditionally focused on pharmaceuticals, this is increasingly applied across diverse fields, significantly expanding its market scope. In the field of toxicology, this is transforming chemical safety evaluations by modeling the impacts of hazardous agents on biological systems, thereby diminishing the reliance on animal testing.

The UAE's strategic focus on becoming a global healthcare and biotechnology hub has driven this adoption. Programs like the National Strategy for Advanced Innovation aim to integrate cutting-edge technologies into various sectors, including healthcare. Dubai Healthcare City and Abu Dhabi's Mubadala Healthcare have partnered with global pharmaceutical companies to explore this for personalized medicine and clinical trial optimization. Additionally, the UAE's focus on medical tourism and incorporating smart technologies into its healthcare infrastructure are key drivers of market growth. These advancements highlight the UAE's commitment to becoming a regional leader in healthcare innovation, making it a lucrative market for biosimulation technologies. Hence, the regional market will grow rapidly in the coming years.

Based on Product, the market is segmented into Software (Molecular Modeling & Simulation Software, Clinical Trial Design Software, PK/PD Modeling and Simulation Software, Pbpk Modeling and Simulation Software, Toxicity Prediction Software, and Other Software Type) and Services (Contract Services, Consulting, and Other Services Type). Based on Pricing Model, the market is segmented into License-based Model, Subscription-based Model, Service-based Model, and Pay Per Use Model. Based on End Use, the market is segmented into Life Sciences Companies, Academic Research Institutions, and Other End Use. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling, and Other Application. Based on Deployment Model, the market is segmented into Cloud-based, On-premises, and Hybrid Model. Based on Therapeutic Area, the market is segmented into Oncology, Cardiovascular Disease, Infectious Disease, Neurological Disorders, and Other Therapeutic Area. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Certara, Inc.
  • Dassault Systemes SE
  • Advanced Chemistry Development, Inc.
  • Genedata AG (Danaher Corporation)
  • Instem Group of Companies
  • Chemical Computing Group ULC
  • Simulations Plus, Inc.
  • Schrodinger, Inc.
  • PPD, Inc. (Thermo Fisher Scientific, Inc.)
  • Physiomics Plc

LAMEA Biosimulation Market Report Segmentation

By Product

  • Software
    • Molecular Modeling & Simulation Software
    • Clinical Trial Design Software
    • PK/PD Modeling and Simulation Software
    • Pbpk Modeling and Simulation Software
    • Toxicity Prediction Software
    • Other Software Type
  • Services
    • Contract Services
    • Consulting
    • Other Services Type

By Pricing Model

  • License-based Model
  • Subscription-based Model
  • Service-based Model
  • Pay Per Use Model

By End Use

  • Life Sciences Companies
  • Academic Research Institutions
  • Other End Use

By Application

  • Drug Discovery & Development
  • Disease Modeling
  • Other Application

By Deployment Model

  • Cloud-based
  • On-premises
  • Hybrid Model

By Therapeutic Area

  • Oncology
  • Cardiovascular Disease
  • Infectious Disease
  • Neurological Disorders
  • Other Therapeutic Area

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Biosimulation Market, by Product
    • 1.4.2 LAMEA Biosimulation Market, by Pricing Model
    • 1.4.3 LAMEA Biosimulation Market, by End Use
    • 1.4.4 LAMEA Biosimulation Market, by Application
    • 1.4.5 LAMEA Biosimulation Market, by Deployment Model
    • 1.4.6 LAMEA Biosimulation Market, by Therapeutic Area
    • 1.4.7 LAMEA Biosimulation Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 Market Share Analysis, 2023
  • 4.2 Strategies Deployed in Biosimulation Market
  • 4.3 Porter Five Forces Analysis

Chapter 5. LAMEA Biosimulation Market by Product

  • 5.1 LAMEA Software Market by Country
  • 5.2 LAMEA Biosimulation Market by Software Type
    • 5.2.1 LAMEA Molecular Modeling & Simulation Software Market by Country
    • 5.2.2 LAMEA Clinical Trial Design Software Market by Country
    • 5.2.3 LAMEA PK/PD Modeling and Simulation Software Market by Country
    • 5.2.4 LAMEA Pbpk Modeling and Simulation Software Market by Country
    • 5.2.5 LAMEA Toxicity Prediction Software Market by Country
    • 5.2.6 LAMEA Other Software Type Market by Country
  • 5.3 LAMEA Services Market by Country
  • 5.4 LAMEA Biosimulation Market by Services Type
    • 5.4.1 LAMEA Contract Services Market by Country
    • 5.4.2 LAMEA Consulting Market by Country
    • 5.4.3 LAMEA Other Services Type Market by Country

Chapter 6. LAMEA Biosimulation Market by Pricing Model

  • 6.1 LAMEA License-based Model Market by Country
  • 6.2 LAMEA Subscription-based Model Market by Country
  • 6.3 LAMEA Service-based Model Market by Country
  • 6.4 LAMEA Pay Per Use Model Market by Country

Chapter 7. LAMEA Biosimulation Market by End Use

  • 7.1 LAMEA Life Sciences Companies Market by Country
  • 7.2 LAMEA Academic Research Institutions Market by Country
  • 7.3 LAMEA Other End Use Market by Country

Chapter 8. LAMEA Biosimulation Market by Application

  • 8.1 LAMEA Drug Discovery & Development Market by Country
  • 8.2 LAMEA Disease Modeling Market by Country
  • 8.3 LAMEA Other Application Market by Country

Chapter 9. LAMEA Biosimulation Market by Deployment Model

  • 9.1 LAMEA Cloud-based Market by Country
  • 9.2 LAMEA On-premises Market by Country
  • 9.3 LAMEA Hybrid Model Market by Country

Chapter 10. LAMEA Biosimulation Market by Therapeutic Area

  • 10.1 LAMEA Oncology Market by Country
  • 10.2 LAMEA Cardiovascular Disease Market by Country
  • 10.3 LAMEA Infectious Disease Market by Country
  • 10.4 LAMEA Neurological Disorders Market by Country
  • 10.5 LAMEA Other Therapeutic Area Market by Country

Chapter 11. LAMEA Biosimulation Market by Country

  • 11.1 Brazil Biosimulation Market
    • 11.1.1 Brazil iosimulation Market by Product
      • 11.1.1.1 Brazil Biosimulation Market by Software Type
      • 11.1.1.2 Brazil Biosimulation Market by Services Type
    • 11.1.2 Brazil Biosimulation Market by Pricing Model
    • 11.1.3 Brazil Biosimulation Market by End Use
    • 11.1.4 Brazil Biosimulation Market by Application
    • 11.1.5 Brazil Biosimulation Market by Deployment Model
    • 11.1.6 Brazil Biosimulation Market by Therapeutic Area
  • 11.2 Argentina Biosimulation Market
    • 11.2.1 Argentina Biosimulation Market by Product
      • 11.2.1.1 Argentina Biosimulation Market by Software Type
      • 11.2.1.2 Argentina Biosimulation Market by Services Type
    • 11.2.2 Argentina Biosimulation Market by Pricing Model
    • 11.2.3 Argentina Biosimulation Market by End Use
    • 11.2.4 Argentina Biosimulation Market by Application
    • 11.2.5 Argentina Biosimulation Market by Deployment Model
    • 11.2.6 Argentina Biosimulation Market by Therapeutic Area
  • 11.3 UAE Biosimulation Market
    • 11.3.1 UAE Biosimulation Market by Product
      • 11.3.1.1 UAE Biosimulation Market by Software Type
      • 11.3.1.2 UAE Biosimulation Market by Services Type
    • 11.3.2 UAE Biosimulation Market by Pricing Model
    • 11.3.3 UAE Biosimulation Market by End Use
    • 11.3.4 UAE Biosimulation Market by Application
    • 11.3.5 UAE Biosimulation Market by Deployment Model
    • 11.3.6 UAE Biosimulation Market by Therapeutic Area
  • 11.4 Saudi Arabia Biosimulation Market
    • 11.4.1 Saudi Arabia Biosimulation Market by Product
      • 11.4.1.1 Saudi Arabia Biosimulation Market by Software Type
      • 11.4.1.2 Saudi Arabia Biosimulation Market by Services Type
    • 11.4.2 Saudi Arabia Biosimulation Market by Pricing Model
    • 11.4.3 Saudi Arabia Biosimulation Market by End Use
    • 11.4.4 Saudi Arabia Biosimulation Market by Application
    • 11.4.5 Saudi Arabia Biosimulation Market by Deployment Model
    • 11.4.6 Saudi Arabia Biosimulation Market by Therapeutic Area
  • 11.5 South Africa Biosimulation Market
    • 11.5.1 South Africa Biosimulation Market by Product
      • 11.5.1.1 South Africa Biosimulation Market by Software Type
      • 11.5.1.2 South Africa Biosimulation Market by Services Type
    • 11.5.2 South Africa Biosimulation Market by Pricing Model
    • 11.5.3 South Africa Biosimulation Market by End Use
    • 11.5.4 South Africa Biosimulation Market by Application
    • 11.5.5 South Africa Biosimulation Market by Deployment Model
    • 11.5.6 South Africa Biosimulation Market by Therapeutic Area
  • 11.6 Nigeria Biosimulation Market
    • 11.6.1 Nigeria Biosimulation Market by Product
      • 11.6.1.1 Nigeria Biosimulation Market by Software Type
      • 11.6.1.2 Nigeria Biosimulation Market by Services Type
    • 11.6.2 Nigeria Biosimulation Market by Pricing Model
    • 11.6.3 Nigeria Biosimulation Market by End Use
    • 11.6.4 Nigeria Biosimulation Market by Application
    • 11.6.5 Nigeria Biosimulation Market by Deployment Model
    • 11.6.6 Nigeria Biosimulation Market by Therapeutic Area
  • 11.7 Rest of LAMEA Biosimulation Market
    • 11.7.1 Rest of LAMEA Biosimulation Market by Product
      • 11.7.1.1 Rest of LAMEA Biosimulation Market by Software Type
      • 11.7.1.2 Rest of LAMEA Biosimulation Market by Services Type
    • 11.7.2 Rest of LAMEA Biosimulation Market by Pricing Model
    • 11.7.3 Rest of LAMEA Biosimulation Market by End Use
    • 11.7.4 Rest of LAMEA Biosimulation Market by Application
    • 11.7.5 Rest of LAMEA Biosimulation Market by Deployment Model
    • 11.7.6 Rest of LAMEA Biosimulation Market by Therapeutic Area

Chapter 12. Company Profiles

  • 12.1 Certara, Inc.
    • 12.1.1 Company Overview
    • 12.1.2 Financial Analysis
    • 12.1.3 Regional Analysis
    • 12.1.4 Research & Development Expenses
    • 12.1.5 Recent strategies and developments:
      • 12.1.5.1 Product Launches and Product Expansions:
      • 12.1.5.2 Acquisition and Mergers:
    • 12.1.6 SWOT Analysis
  • 12.2 Dassault Systemes SE
    • 12.2.1 Company Overview
    • 12.2.2 Financial Analysis
    • 12.2.3 Regional Analysis
    • 12.2.4 Research & Development Expense
    • 12.2.5 SWOT Analysis
  • 12.3 Advanced Chemistry Development, Inc.
    • 12.3.1 Company Overview
  • 12.4 Genedata AG (Danaher Corporation)
    • 12.4.1 Company Overview
    • 12.4.2 Financial Analysis
    • 12.4.3 Segmental and Regional Analysis
    • 12.4.4 Research & Development Expense
    • 12.4.5 Recent strategies and developments:
      • 12.4.5.1 Partnerships, Collaborations, and Agreements:
  • 12.5 Instem Group of Companies
    • 12.5.1 Company Overview
  • 12.6 Chemical Computing Group ULC
    • 12.6.1 Company Overview
  • 12.7 Simulations Plus, Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Financial Analysis
    • 12.7.3 Segmental and Regional Analysis
    • 12.7.4 Research & Development Expenses
    • 12.7.5 Recent strategies and developments:
      • 12.7.5.1 Partnerships, Collaborations, and Agreements:
      • 12.7.5.2 Product Launches and Product Expansions:
      • 12.7.5.3 Acquisition and Mergers:
    • 12.7.6 SWOT Analysis
  • 12.8 Schrodinger, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Financial Analysis
    • 12.8.3 Segmental and Regional Analysis
    • 12.8.4 Research & Development Expenses
  • 12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
    • 12.9.1 Company Overview
    • 12.9.2 Financial Analysis
    • 12.9.3 Segmental and Regional Analysis
    • 12.9.4 Research & Development Expenses
  • 12.10. Physiomics Plc
    • 12.10.1 Company Overview
    • 12.10.2 Financial Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 2 LAMEA Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 3 LAMEA Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 4 LAMEA Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 5 LAMEA Software Market by Country, 2020 - 2023, USD Million
  • TABLE 6 LAMEA Software Market by Country, 2024 - 2031, USD Million
  • TABLE 7 LAMEA Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 8 LAMEA Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 9 LAMEA Molecular Modeling & Simulation Software Market by Country, 2020 - 2023, USD Million
  • TABLE 10 LAMEA Molecular Modeling & Simulation Software Market by Country, 2024 - 2031, USD Million
  • TABLE 11 LAMEA Clinical Trial Design Software Market by Country, 2020 - 2023, USD Million
  • TABLE 12 LAMEA Clinical Trial Design Software Market by Country, 2024 - 2031, USD Million
  • TABLE 13 LAMEA PK/PD Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
  • TABLE 14 LAMEA PK/PD Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
  • TABLE 15 LAMEA Pbpk Modeling and Simulation Software Market by Country, 2020 - 2023, USD Million
  • TABLE 16 LAMEA Pbpk Modeling and Simulation Software Market by Country, 2024 - 2031, USD Million
  • TABLE 17 LAMEA Toxicity Prediction Software Market by Country, 2020 - 2023, USD Million
  • TABLE 18 LAMEA Toxicity Prediction Software Market by Country, 2024 - 2031, USD Million
  • TABLE 19 LAMEA Other Software Type Market by Country, 2020 - 2023, USD Million
  • TABLE 20 LAMEA Other Software Type Market by Country, 2024 - 2031, USD Million
  • TABLE 21 LAMEA Services Market by Country, 2020 - 2023, USD Million
  • TABLE 22 LAMEA Services Market by Country, 2024 - 2031, USD Million
  • TABLE 23 LAMEA Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 24 LAMEA Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 25 LAMEA Contract Services Market by Country, 2020 - 2023, USD Million
  • TABLE 26 LAMEA Contract Services Market by Country, 2024 - 2031, USD Million
  • TABLE 27 LAMEA Consulting Market by Country, 2020 - 2023, USD Million
  • TABLE 28 LAMEA Consulting Market by Country, 2024 - 2031, USD Million
  • TABLE 29 LAMEA Other Services Type Market by Country, 2020 - 2023, USD Million
  • TABLE 30 LAMEA Other Services Type Market by Country, 2024 - 2031, USD Million
  • TABLE 31 LAMEA Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 32 LAMEA Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 33 LAMEA License-based Model Market by Country, 2020 - 2023, USD Million
  • TABLE 34 LAMEA License-based Model Market by Country, 2024 - 2031, USD Million
  • TABLE 35 LAMEA Subscription-based Model Market by Country, 2020 - 2023, USD Million
  • TABLE 36 LAMEA Subscription-based Model Market by Country, 2024 - 2031, USD Million
  • TABLE 37 LAMEA Service-based Model Market by Country, 2020 - 2023, USD Million
  • TABLE 38 LAMEA Service-based Model Market by Country, 2024 - 2031, USD Million
  • TABLE 39 LAMEA Pay Per Use Model Market by Country, 2020 - 2023, USD Million
  • TABLE 40 LAMEA Pay Per Use Model Market by Country, 2024 - 2031, USD Million
  • TABLE 41 LAMEA Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 42 LAMEA Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 43 LAMEA Life Sciences Companies Market by Country, 2020 - 2023, USD Million
  • TABLE 44 LAMEA Life Sciences Companies Market by Country, 2024 - 2031, USD Million
  • TABLE 45 LAMEA Academic Research Institutions Market by Country, 2020 - 2023, USD Million
  • TABLE 46 LAMEA Academic Research Institutions Market by Country, 2024 - 2031, USD Million
  • TABLE 47 LAMEA Other End Use Market by Country, 2020 - 2023, USD Million
  • TABLE 48 LAMEA Other End Use Market by Country, 2024 - 2031, USD Million
  • TABLE 49 LAMEA Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 50 LAMEA Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 51 LAMEA Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
  • TABLE 52 LAMEA Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
  • TABLE 53 LAMEA Disease Modeling Market by Country, 2020 - 2023, USD Million
  • TABLE 54 LAMEA Disease Modeling Market by Country, 2024 - 2031, USD Million
  • TABLE 55 LAMEA Other Application Market by Country, 2020 - 2023, USD Million
  • TABLE 56 LAMEA Other Application Market by Country, 2024 - 2031, USD Million
  • TABLE 57 LAMEA Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 58 LAMEA Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 59 LAMEA Cloud-based Market by Country, 2020 - 2023, USD Million
  • TABLE 60 LAMEA Cloud-based Market by Country, 2024 - 2031, USD Million
  • TABLE 61 LAMEA On-premises Market by Country, 2020 - 2023, USD Million
  • TABLE 62 LAMEA On-premises Market by Country, 2024 - 2031, USD Million
  • TABLE 63 LAMEA Hybrid Model Market by Country, 2020 - 2023, USD Million
  • TABLE 64 LAMEA Hybrid Model Market by Country, 2024 - 2031, USD Million
  • TABLE 65 LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 66 LAMEA Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 67 LAMEA Oncology Market by Country, 2020 - 2023, USD Million
  • TABLE 68 LAMEA Oncology Market by Country, 2024 - 2031, USD Million
  • TABLE 69 LAMEA Cardiovascular Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 70 LAMEA Cardiovascular Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 71 LAMEA Infectious Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 72 LAMEA Infectious Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 73 LAMEA Neurological Disorders Market by Country, 2020 - 2023, USD Million
  • TABLE 74 LAMEA Neurological Disorders Market by Country, 2024 - 2031, USD Million
  • TABLE 75 LAMEA Other Therapeutic Area Market by Country, 2020 - 2023, USD Million
  • TABLE 76 LAMEA Other Therapeutic Area Market by Country, 2024 - 2031, USD Million
  • TABLE 77 LAMEA Biosimulation Market by Country, 2020 - 2023, USD Million
  • TABLE 78 LAMEA Biosimulation Market by Country, 2024 - 2031, USD Million
  • TABLE 79 Brazil Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 80 Brazil Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 81 Brazil Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 82 Brazil Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 83 Brazil Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 84 Brazil Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 85 Brazil Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 86 Brazil Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 87 Brazil Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 88 Brazil Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 89 Brazil Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 90 Brazil Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 91 Brazil Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 92 Brazil Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 93 Brazil Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 94 Brazil Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 95 Brazil Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 96 Brazil Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 97 Argentina Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 98 Argentina Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 99 Argentina Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 100 Argentina Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 101 Argentina Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 102 Argentina Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 103 Argentina Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 104 Argentina Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 105 Argentina Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 106 Argentina Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 107 Argentina Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 108 Argentina Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 109 Argentina Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 110 Argentina Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 111 Argentina Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 112 Argentina Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 113 Argentina Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 114 Argentina Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 115 UAE Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 116 UAE Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 117 UAE Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 118 UAE Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 119 UAE Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 120 UAE Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 121 UAE Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 122 UAE Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 123 UAE Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 124 UAE Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 125 UAE Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 126 UAE Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 127 UAE Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 128 UAE Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 129 UAE Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 130 UAE Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 131 UAE Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 132 UAE Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 133 Saudi Arabia Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 134 Saudi Arabia Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 135 Saudi Arabia Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 136 Saudi Arabia Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 137 Saudi Arabia Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 138 Saudi Arabia Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 139 Saudi Arabia Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 140 Saudi Arabia Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 141 Saudi Arabia Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 142 Saudi Arabia Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 143 Saudi Arabia Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 144 Saudi Arabia Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 145 Saudi Arabia Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 146 Saudi Arabia Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 147 Saudi Arabia Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 148 Saudi Arabia Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 149 Saudi Arabia Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 150 Saudi Arabia Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 151 South Africa Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 152 South Africa Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 153 South Africa Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 154 South Africa Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 155 South Africa Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 156 South Africa Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 157 South Africa Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 158 South Africa Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 159 South Africa Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 160 South Africa Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 161 South Africa Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 162 South Africa Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 163 South Africa Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 164 South Africa Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 165 South Africa Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 166 South Africa Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 167 South Africa Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 168 South Africa Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 169 Nigeria Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 170 Nigeria Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 171 Nigeria Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 172 Nigeria Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 173 Nigeria Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 174 Nigeria Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 175 Nigeria Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 176 Nigeria Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 177 Nigeria Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 178 Nigeria Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 179 Nigeria Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 180 Nigeria Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 181 Nigeria Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 182 Nigeria Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 183 Nigeria Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 184 Nigeria Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 185 Nigeria Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 186 Nigeria Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 187 Rest of LAMEA Biosimulation Market, 2020 - 2023, USD Million
  • TABLE 188 Rest of LAMEA Biosimulation Market, 2024 - 2031, USD Million
  • TABLE 189 Rest of LAMEA Biosimulation Market by Product, 2020 - 2023, USD Million
  • TABLE 190 Rest of LAMEA Biosimulation Market by Product, 2024 - 2031, USD Million
  • TABLE 191 Rest of LAMEA Biosimulation Market by Software Type, 2020 - 2023, USD Million
  • TABLE 192 Rest of LAMEA Biosimulation Market by Software Type, 2024 - 2031, USD Million
  • TABLE 193 Rest of LAMEA Biosimulation Market by Services Type, 2020 - 2023, USD Million
  • TABLE 194 Rest of LAMEA Biosimulation Market by Services Type, 2024 - 2031, USD Million
  • TABLE 195 Rest of LAMEA Biosimulation Market by Pricing Model, 2020 - 2023, USD Million
  • TABLE 196 Rest of LAMEA Biosimulation Market by Pricing Model, 2024 - 2031, USD Million
  • TABLE 197 Rest of LAMEA Biosimulation Market by End Use, 2020 - 2023, USD Million
  • TABLE 198 Rest of LAMEA Biosimulation Market by End Use, 2024 - 2031, USD Million
  • TABLE 199 Rest of LAMEA Biosimulation Market by Application, 2020 - 2023, USD Million
  • TABLE 200 Rest of LAMEA Biosimulation Market by Application, 2024 - 2031, USD Million
  • TABLE 201 Rest of LAMEA Biosimulation Market by Deployment Model, 2020 - 2023, USD Million
  • TABLE 202 Rest of LAMEA Biosimulation Market by Deployment Model, 2024 - 2031, USD Million
  • TABLE 203 Rest of LAMEA Biosimulation Market by Therapeutic Area, 2020 - 2023, USD Million
  • TABLE 204 Rest of LAMEA Biosimulation Market by Therapeutic Area, 2024 - 2031, USD Million
  • TABLE 205 Key Information - Certara, Inc.
  • TABLE 206 Key Information - Dassault Systemes SE
  • TABLE 207 Key Information - Advanced Chemistry Development, Inc.
  • TABLE 208 Key Information - Genedata AG
  • TABLE 209 Key Information - Instem Group of Companies
  • TABLE 210 Key Information - Chemical Computing Group ULC
  • TABLE 211 Key Information - Simulations Plus, Inc.
  • TABLE 212 Key Information - Schrodinger, Inc.
  • TABLE 213 Key Information - PPD, Inc.
  • TABLE 214 Key Information - Physiomics Plc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!